SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    TomatisL, ed. Cancer causes, occurrence and control. No. 100. Lyon: IARC, 1990.
  • 2
    Parkin DM, Laara E, Muir CS. Estimates of worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;41: 18497.
  • 3
    Parkin DM, Pisani P, Ferlay J. Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54: 594606.
  • 4
    Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention, and projections of future burden. Int J Cancer 1993;55: 891903.
  • 5
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1999;80: 82741.
  • 6
    Pisani P, Parkin DM, Bray FI et al. Estimates of the worldwide mortality from twenty-five major cancers in 1990. Implications for prevention, and projections of future burden. Int J Cancer 1999;83: 1829.
  • 7
    Hakulinen T, Hansluwka, Lopez AD, et al. Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol 1986;15: 22733.
  • 8
    Bulatao RA, Stevens PW. Estimates and projections of mortality by cause: a global overview, 1970-2015. In: JamiesonDT, MosleyWH, eds. Evolving health sector priorities in developing countries. Washington: Population, Health and Nutrition Division, The World Bank, 1989.
  • 9
    Murray CJL, Lopez A. The global burden of disease. Cambridge, MA: Harvard University Press, 1996.
  • 10
    Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997;349: 143642.
  • 11
    Preston HS. Mortality patterns in national populations. New York: Academic Press, 1976.
  • 12
    Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No. 5. Lyon: IARC, 2001.
  • 13
    JensenOM, ParkinDM, MacLennanR, et al., eds. Cancer registration principles and methods. IARC Sci. Publ. No. 95. Lyon: IARC, 1991.
  • 14
    ParkinDM, WhelanSL, FerlayJ, et al., Eds. Cancer incidence in five continents, vol. VII. No. 143. Lyon: IARC, 1997. p 10289.
  • 15
    RiesLA, KosaryCL, HankeyBF, et al., eds. SEER cancer statistics review 1973–1994. NIH Publication No. 97-2789. Bethesda, MD: U.S. Dept. of Health and Human Services, NCI, 1997.
  • 16
    Berrino F, Capocaccia R, Estève J, et al. Survival of cancer patients in Europe. The EUROCARE-2 study. IARC Sci. Publ. No. 151. Lyon: IARC, 1999.
  • 17
    SankaranarayananR, BlackRJ, ParkinDM, eds. Cancer survival in developing countries. IARC Sci. Publ. No. 145. Lyon: IARC, 1998.
  • 18
    Aoki K, Tominaga S, Hirayama T, et al. Cancer prevention in developing countries. Nagoya, Japan: University of Nagoya Press (for UICC), 1982.
  • 19
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1999;80: 82741.
  • 20
    Rothman KJ, Greenland S. Modern epidemiology, 2nd ed. Philadelphia: Lippincot-Raven, 1998.
  • 21
    Ferlay J, Bray F, Sankila R et al. EUCAN: cancer incidence, mortality and prevalence in the European Union 1996, version 3.1. IARC Cancer Base No. 4. Lyon: IARC, 1999. Limited version available from: URL: http://www-dep.iarc.fr/eucan/eucan.htm
  • 22
    Pisani F, Bray F, Parkin DM. Estimates of the worldwide prevalence of cancer for twenty-five sites in the adult population. Int J Cancer, in press.
  • 23
    United Nations. World population prospects: the 1998 revision. vol. 1: comprehensive tables. New York: United Nations, 1999.
  • 24
    Hakama M, Hakulinen T, Teppo L, et al. Incidence, mortality or prevalence as indicators of the cancer problem. Cancer 1975;36: 222731.
  • 25
    Feldman AR, Kessler L, Myers MH, et al. The prevalence of cancer: estimates based upon the Connecticut Tumor Registry. N Engl J Med 1986;315: 13947.
  • 26
    Tulinius H, Storm H, Paulla E, et al. Cancer in the Nordic countries 1981–1992. Acta Path Microbiol Scand 1982; 100, (suppl 31): 14670.
  • 27
    Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst 1999;91: 14806.
  • 28
    Capocaccia R, Verdecchia A, Micheli A, et al. Breast cancer incidence and prevalence estimated from survival and mortality. Cancer Causes Control 1990;1: 239.
  • 29
    Merrill RM, Capocaccia R, Feuer EJ, et al. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) program. Int J Epidemiol 2000;29: 197207.
  • 30
    Coldman AJ, McBride M, Braun T. Calculating the prevalence of cancer. Stat Med 1992;11: 157989.
  • 31
    Murray JL, Axtell LM. Impact of cancer: years of life lost due to cancer mortality. J Natl Cancer Inst 1974;52: 37.
  • 32
    Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Org 1994;72: 42945.
  • 33
    Morrow RH, Bryant JH. Health policy approaches to measuring and valuing human life: conceptual and ethical issues. Am J Public Health 1995;85: 135660.